Multiinstitutional study on evaluation methods of renal function before and during chemotherapy for urothelial cancer
Not Applicable
- Conditions
- nresectable or metastatic urothelial carcinoma treated with systemic chemotherapy
- Registration Number
- JPRN-UMIN000007601
- Lead Sponsor
- Department of Urology, Tsukuba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 370
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients given the first systemic chemotherapy before December 31, 2003. 2. Patients with active cancers in other organs at the start of systemic chemotherapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of dose modification in the 1st-line chemotherapy.
- Secondary Outcome Measures
Name Time Method 1. The rate of regimen modification in the 1st-line chemotherapy. 2. Response rate in the 1st-line chemotherapy. 3. Overall survival rate. 4. Cancer-specific survival rate 5. Frequency of adverse effects. 6. Response rate in the 2nd-line chemotherapy. 7. Response rate in the 3rd-line chemotherapy. 8. Correlation among the measured results in renal function by different methods.